MicroRNA-Based Targeted Therapy in Pancreatic Cancer
Pancreatic cancer (PC) is that the fourth leading reason behind cancer-related deaths within the us and includes a median 5-year survival rate but less than 5%. Though surgery offers the simplest likelihood for a cure for carcinoma, but 20% of patients are eligible for doubtless curative surgery, as a result of in most cases, the […]
MicroRNA-Based Targeted Therapy in Pancreatic Cancer Read More »